Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.52)
# 288
Out of 5,143 analysts
76
Total ratings
50.67%
Success rate
35.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $5.68 | +287.32% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $2.47 | +304.86% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $7.63 | +424.25% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.05 | +852.38% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $13.61 | -55.91% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $5.67 | +129.28% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $19.57 | +2.20% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.47 | +320.48% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $58.34 | +28.56% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $12.02 | +199.50% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.66 | +2,167.23% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $9.78 | +155.62% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $47.02 | +6.34% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $5.68
Upside: +287.32%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $2.47
Upside: +304.86%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $7.63
Upside: +424.25%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.05
Upside: +852.38%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $13.61
Upside: -55.91%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $5.67
Upside: +129.28%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $19.57
Upside: +2.20%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.47
Upside: +320.48%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $58.34
Upside: +28.56%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $12.02
Upside: +199.50%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.66
Upside: +2,167.23%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $9.78
Upside: +155.62%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $47.02
Upside: +6.34%